Anna López-Ferrer Selected Research

Mucins

11/2002

Differences in the O-glycosylation patterns between lung squamous cell carcinoma and adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna López-Ferrer Research Topics

Disease

14	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2023 - 01/2012
2	Psoriatic Arthritis 12/2023 - 01/2012
2	Arthritis (Polyarthritis) 01/2023 - 01/2012
2	Colonic Neoplasms (Colon Cancer) 07/2007 - 01/2002
2	Neoplasms (Cancer) 07/2007 - 11/2002
2	Adenocarcinoma 03/2005 - 11/2002
1	Hidradenitis Suppurativa 01/2023
1	Obesity 06/2016
1	Infections 01/2015
1	Candidiasis (Moniliasis) 01/2015
1	Pityriasis Rubra Pilaris 03/2014
1	Exanthema (Rash) 01/2012
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2012
1	Necrosis 01/2012
1	Sarcoidosis (Schaumann Disease) 01/2012
1	Pityriasis Lichenoides (Pityriasis Lichenoides et Varioliformis Acuta) 07/2010
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2002
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2002

Drug/Important Bio-Agent (IBA)

4	secukinumabIBA 01/2023 - 01/2015
4	Ustekinumab (CNTO 1275)FDA Link 01/2023 - 01/2012
4	Adalimumab (Humira)FDA Link 01/2023 - 01/2012
3	guselkumabIBA 06/2022 - 01/2022
3	Etanercept (Enbrel)FDA Link 10/2019 - 01/2015
3	Lewis Blood Group AntigensIBA 07/2007 - 01/2002
2	Interleukin-17 (Interleukin 17)IBA 01/2023 - 01/2015
2	Biosimilar PharmaceuticalsIBA 11/2022 - 10/2019
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
2	Infliximab (Remicade)FDA Link 10/2019 - 07/2010
2	CarbohydratesIBA 03/2005 - 11/2002
1	tildrakizumabIBA 12/2023
1	bimekizumabIBA 01/2023
1	CytokinesIBA 01/2015
1	Monoclonal AntibodiesIBA 01/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2014
1	Acitretin FDA Link 03/2014
1	Therapeutic UsesIBA 01/2012
1	Tumor Necrosis Factor InhibitorsIBA 01/2012
1	Methotrexate (Mexate)FDA LinkGeneric 07/2010
1	AntigensIBA 07/2007
1	Sialyl Lewis X AntigenIBA 07/2007
1	FucosyltransferasesIBA 07/2007
1	Messenger RNA (mRNA)IBA 03/2005
1	SialyltransferasesIBA 03/2005
1	Periodic AcidIBA 11/2002
1	Amylases FDA Link 11/2002
1	GlycosyltransferasesIBA 11/2002
1	MucinsIBA 11/2002

Therapy/Procedure

2	Biological Therapy 12/2023 - 06/2022
2	Therapeutics 01/2022 - 01/2012
1	Photochemotherapy (Photodynamic Therapy) 03/2014